ASIH Stockholm Södra, Långbro Park, Palliative Home Care and Hospice Ward, Bergtallsvägen 12, SE-125 59 Älvsjö, Sweden.
Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Huddinge, SE-141 86 Stockholm, Sweden.
Int J Mol Sci. 2017 Oct 18;18(10):2170. doi: 10.3390/ijms18102170.
Vitamin D is a hormone synthesized in the skin in the presence of sunlight. Like other hormones, vitamin D plays a role in a wide range of processes in the body. Here we review the possible role of vitamin D in nociceptive and inflammatory pain. In observational studies, low vitamin D levels have been associated with increased pain and higher opioid doses. Recent interventional studies have shown promising effects of vitamin D supplementation on cancer pain and muscular pain-but only in patients with insufficient levels of vitamin D when starting intervention. Possible mechanisms for vitamin D in pain management are the anti-inflammatory effects mediated by reduced cytokine and prostaglandin release and effects on T-cell responses. The recent finding of vitamin D-mediated inhibition of Prostaglandin E2 (PGE2) is especially interesting and exhibits a credible mechanistic explanation. Having reviewed current literature, we suggest that patients with deficient levels defined as 25-hydroxyvitamin D (25-OHD) levels <30 nmol/L are most likely to benefit from supplementation, while individuals with 25-OHD >50 nmol/L probably have little benefit from supplementation. Our conclusion is that vitamin D may constitute a safe, simple and potentially beneficial way to reduce pain among patients with vitamin D deficiency, but that more randomized and placebo-controlled studies are needed before any firm conclusions can be drawn.
维生素 D 是一种在阳光照射下皮肤合成的激素。像其他激素一样,维生素 D 在身体的广泛过程中发挥作用。在这里,我们回顾了维生素 D 在伤害性和炎症性疼痛中的可能作用。在观察性研究中,低维生素 D 水平与疼痛增加和阿片类药物剂量增加有关。最近的干预性研究表明,维生素 D 补充剂对癌症疼痛和肌肉疼痛有积极作用-但仅在开始干预时维生素 D 水平不足的患者中。维生素 D 管理疼痛的可能机制是通过减少细胞因子和前列腺素释放介导的抗炎作用,以及对 T 细胞反应的影响。最近发现维生素 D 介导的前列腺素 E2 (PGE2) 抑制作用尤其有趣,并表现出可信的机制解释。在回顾了目前的文献后,我们建议将 25-羟维生素 D(25-OHD)水平<30 nmol/L 的缺乏水平定义为最有可能受益于补充的患者,而 25-OHD >50 nmol/L 的患者可能从补充中获益甚少。我们的结论是,维生素 D 可能是一种安全、简单且具有潜在益处的方法,可以减少维生素 D 缺乏症患者的疼痛,但需要更多的随机和安慰剂对照研究才能得出任何确定的结论。